The medicine experience may be the part of psychedelic-assisted therapy that gets the most attention, but modern clinical research rarely treats dosing as a stand-alone event. Preparation before dosing and integration afterward help create the therapeutic structure around the experience – clarifying safety, expectations, trust, intentions, and what happens when ordinary life returns.
THE SHORT ANSWER
Preparation helps a person understand what they are entering, build trust with the therapeutic team, clarify expectations and intentions, identify important patterns and supports, and plan for difficult moments before a psychedelic experience begins.
Integration helps the person make sense of what happened afterward and decide what, if anything, should change in everyday life. It can include emotional processing, values work, trauma-focused therapy, relationship work, behavioral change, and time to understand experiences that are still unfolding.
Why this matters: Published psilocybin-assisted therapy protocols consistently include preparation before dosing and integration afterward, even though the exact therapy model varies across studies.
Psychedelic-assisted therapy is often discussed as though the medicine itself is the treatment.
A person takes psilocybin. They have an experience. Something changes.
But that description leaves out much of what actually happens in carefully structured clinical research.
Before the dosing day, there is preparation.
Afterward, there is integration.
And during the experience, there is a therapeutic team, a protocol, attention to safety, and a carefully considered setting.
The dosing session may be the most visible part of psychedelic-assisted therapy. It is not the only part.
This is something members of our Serenity clinical team, including Nicole and Bailey, see directly through their work as therapists in psychedelic-assisted therapy research conducted within approved clinical research settings.
That research work is separate from Serenity. Serenity does not provide psilocybin therapy.
But working inside structured research protocols has deepened the way we think about preparation, therapeutic support, integration, psychological flexibility, and the difference between having an experience and creating lasting change.
Those lessons also influence how we approach Ketamine-Assisted Psychotherapy at Serenity, while recognizing that ketamine and classic psychedelics such as psilocybin are different medicines with different mechanisms and evidence bases.
What Does Preparation Mean in Psychedelic-Assisted Therapy?
Preparation is the therapeutic and practical work that happens before the psychedelic dosing session.
It is not simply reviewing the appointment time and signing consent forms.
Across published clinical trials, preparation commonly includes education about what to expect, development of the therapeutic relationship, discussion of intentions and concerns, safety planning, and helping the participant understand how to approach the experience.
A systematic review of psilocybin-assisted psychotherapy protocols found that all reviewed protocols included preparation before dosing and integration afterward, although the number of sessions, length, and specific psychotherapy model varied.
That consistency tells us something important: even in a field where many treatment details are still being studied, preparation has remained a core part of the therapeutic container.
Preparation Helps Establish Safety Before the Experience Begins
Safety begins long before the medicine is administered.
In clinical research, protocols include eligibility criteria, medical and psychiatric screening, informed consent, and plans for monitoring participants during and after dosing.
Therapeutic preparation adds another layer.
The therapist wants to understand:
- What is bringing this person into treatment?
- What symptoms or experiences are they struggling with?
- What is their trauma and mental health history?
- How do they typically respond when they feel afraid, overwhelmed, out of control, or emotionally exposed?
- What helps them feel grounded?
- What fears do they have about the medicine experience?
- What expectations are they carrying into the session?
- Who and what will support them afterward?
Preparation does not make an altered-state experience completely predictable. It helps the person and therapist understand the landscape before entering something that may be unfamiliar.
Preparation Builds the Therapeutic Relationship
One of the most important parts of preparation is not a worksheet or technique.
It is trust.
During a psychedelic experience, a person may feel emotionally open, vulnerable, disoriented, frightened, deeply connected, or temporarily less able to rely on their usual defenses.
Meeting the therapists for the first time on dosing day would leave very little opportunity to establish how the person communicates distress, what helps them feel safe, or whether they trust the people supporting them.
Research increasingly points to the therapeutic alliance as an important part of psychedelic-assisted therapy. In one psilocybin-assisted therapy trial for major depressive disorder, a stronger therapeutic alliance during preparation was associated with better depression outcomes at later follow-ups and with greater psychological insight during the acute experience.
That study does not prove that alliance alone caused the outcome, but it reinforces something clinicians already recognize:
Who is with you – and whether you trust them – may matter when you are entering a psychologically vulnerable experience.
Preparation Helps Shape Expectations Without Trying to Control the Experience
People often arrive with expectations.
They may have heard dramatic stories online.
They may expect a mystical experience, a childhood memory, a feeling of ego dissolution, an answer to a relationship problem, or a single breakthrough that changes everything.
Preparation gives us a chance to separate intention from demand.
An intention might be:
- I want to understand what keeps me disconnected from the people I love.
- I want to become more willing to feel grief instead of avoiding it.
- I want to explore what a life guided by my values would look like.
- I want to approach myself with more compassion.
A demand sounds more like:
- I need to see a specific person.
- I have to get an answer.
- I need this to cure my depression today.
- If I do not have a profound experience, the treatment did not work.
Preparation can give the experience a direction without requiring it to follow a script.
Preparation Can Increase Psychological Flexibility Before Dosing
Another important part of preparation is helping a person develop a different relationship with what may arise.
At Serenity, ACT principles strongly influence the way we think about this work.
Rather than preparing someone to control every thought, sensation, or emotion, we may focus on psychological flexibility:
- Can you notice fear without immediately deciding something is wrong?
- Can you become curious about an emotion instead of pushing it away?
- Can you recognize a thought as a thought rather than an unquestionable fact?
- Can you remember what matters to you even when the experience becomes uncomfortable?
This does not mean telling someone to surrender to anything that feels unsafe. It means increasing their capacity to remain curious, communicate, and respond flexibly rather than assuming discomfort automatically means failure.
Preparation Also Includes Practical Anchors
Good preparation can be very practical.
A person may identify music that feels supportive, words they want to remember, people who represent safety, meaningful objects, breathing or grounding strategies, or ways to communicate if they become frightened or need help.
These are not guarantees that a difficult moment will disappear.
They are reminders that the person is entering the experience with resources, a therapeutic relationship, and a plan.
What Does Research Say About Preparation?
Preparation is one of the most consistent elements across modern psychedelic-assisted therapy protocols.
A 2024 systematic review of psilocybin-assisted psychotherapy for depression found that all identified protocols included preparation before dosing, supportive monitoring during dosing, and integration afterward.
A 2026 systematic review and meta-analysis of controlled trials for depressive symptoms went a step further. Across the included studies, greater hours of preparation therapy were associated with larger reductions in depressive symptoms.
That result is interesting, but it should be interpreted carefully. Most of the included studies had high risk of bias, and the finding is an association across trials rather than proof that adding a particular number of preparation hours will cause a better outcome for an individual.
Still, it supports a question the field is increasingly taking seriously:
The medicine matters – but what happens before the medicine may matter too.
What Is Integration in Psychedelic-Assisted Therapy?
Integration is the work that happens after the psychedelic experience.
It is commonly described as the process of understanding the experience and applying what is useful from it to everyday life.
That may sound simple. In practice, integration can involve many different things.
A person might feel inspired.
They might feel emotionally raw.
They may have a powerful insight but have no idea what to do with it.
They may be disappointed that the experience was not what they expected.
They may feel that something important happened but be unable to explain it.
Integration gives those experiences somewhere to go.
Integration Is Not About Decoding Every Image
One of the easiest mistakes in integration is assuming that every image, symbol, or memory has to contain a hidden message.
A psychedelic experience can include vivid imagery, unusual associations, memories, emotions, body sensations, altered time, and experiences that are difficult to put into ordinary language.
The therapist’s job is not to tell the client what any of it means.
We may ask:
- What stood out?
- What emotion was connected to it?
- What does it bring up for you now?
- Does this connect with something already happening in your life or therapy?
- What feels useful to keep exploring?
Sometimes an image becomes deeply meaningful. Sometimes it does not.
Integration should create curiosity, not certainty where certainty does not exist.
Integration Connects the Experience Back to Real Life
A person can feel profound compassion during a psychedelic experience and return home to the same self-critical habits.
They can realize how much a relationship matters and still avoid the conversation that needs to happen.
They can feel connected to a value and then return to routines that do not reflect it.
That is why the question after a meaningful experience cannot only be:
What did you see?
It also has to become:
What does this invite you to do differently?
Different Therapeutic Tools May Be Used During Integration
There is no single therapy model that has been established as the universal best approach for psychedelic integration.
Research reviews show that current psychedelic-assisted therapy protocols use a range of therapeutic frameworks.
In research settings, Nicole and Bailey follow the approved study protocol for that particular trial. The protocol determines what is covered, how sessions are structured, and what therapeutic approach can be used.
At Serenity, Ketamine-Assisted Psychotherapy is more individualized. Depending on the client and what emerges, integration may draw from several therapeutic tools.
ACT: Psychological Flexibility, Values, and Action
ACT can help a client notice whether the experience created more room around a thought, fear, identity, or pattern.
Integration may explore:
- What are you more willing to feel now?
- What story feels less rigid?
- What have you been avoiding?
- What value became clearer?
- What action would move you toward that value?
ACT helps move the conversation from insight toward flexibility and committed action.
IFS-Informed Work: Protective Responses and Vulnerable Emotions
An experience may make someone more aware of an internal protective response:
- Do not trust anyone.
- Stay in control.
- Do not let yourself need people.
- Do not feel this.
- Go back to the way things were.
IFS-informed work can help us become curious about what that response has been protecting rather than immediately trying to eliminate it.
Sometimes that creates access to grief, fear, shame, loneliness, anger, or vulnerability that has been difficult to approach directly.
EMDR: When Trauma Material Needs More Structured Processing
When a medicine experience brings forward trauma-related memories, beliefs, body responses, or emotional themes, EMDR may be considered when clinically appropriate and when the client is adequately prepared.
The point is not to assume every difficult image is a trauma target.
But when a clear memory or belief such as “I am not safe,” “It was my fault,” or “I am powerless” connects with established trauma work, EMDR may offer a more structured way to continue processing after the medicine experience.
Integration May Also Mean Slowing Down
Not every experience needs an immediate lesson.
Sometimes integration is about tolerating not knowing yet.
A person may need time to sleep, journal, walk, talk with a therapist, reconnect with family, or simply notice what changes over the next several days.
Trying too hard to extract meaning can become another form of control.
Sometimes the work is not finding the answer. It is giving the experience enough space for the important questions to become clearer.
What If the Psychedelic Experience Was Difficult?
Preparation and integration become especially important when an experience is frightening, confusing, emotionally intense, or disappointing.
A challenging experience should not automatically be reframed as a breakthrough.
The therapist may help the person:
- Reorient to the present
- Understand what remains emotionally activated
- Separate the acute experience from current reality
- Work with fear or disappointment
- Identify whether trauma material was activated
- Determine whether additional support is needed
- Decide whether another dosing experience should be delayed or reconsidered
If someone develops significant safety concerns, prolonged confusion, mania, psychosis, suicidal risk, or another serious psychiatric or medical change, that requires appropriate clinical evaluation rather than simply being labeled an integration issue.
Preparation and Integration Are Not About Manufacturing a ‘Perfect’ Psychedelic Experience
A well-prepared person can still have a difficult session.
A beautifully integrated experience can still leave unanswered questions.
Preparation does not guarantee a mystical experience.
Integration does not guarantee that insight becomes permanent.
Their value is more practical:
They create a therapeutic structure for approaching the experience with greater safety, context, reflection, and intention.
What Our Research Experience Has Taught Us
For Nicole and Bailey, working as therapists in psychedelic-assisted therapy research has made the importance of the therapeutic container especially visible.
In research, the medicine is never simply handed to a participant without structure.
There are protocols.
There is screening.
There are preparation sessions.
There is support during dosing.
There are integration sessions afterward.
There is documentation, monitoring, and attention to safety.
The exact process varies by trial, and research protocols are not interchangeable with clinical KAP.
But the larger lesson has influenced our clinical philosophy:
A medicine can create an experience. Therapy helps create a context for what happens before it, during it, and after it.
Current MD Anderson Psychedelic-Assisted Therapy Research
The University of Texas MD Anderson Cancer Center currently has Phase II clinical research examining psilocybin-assisted psychotherapy for depression and/or anxiety in people with advanced cancer and in cancer survivors.
Members of Serenity’s clinical team participate as therapists in approved psychedelic-assisted therapy research settings. That work is separate from Serenity’s clinical services.
Serenity does not provide psilocybin treatment.
We share this distinction clearly because research participation and legal clinical treatment are not the same thing.
How These Lessons Influence Ketamine-Assisted Psychotherapy at Serenity
Ketamine is not psilocybin, and findings from psilocybin research should not automatically be applied to ketamine.
But the research environment has strengthened several principles we bring into our KAP work:
- Do not skip preparation simply because someone is eager to dose.
- Make room for fear, expectations, and uncertainty before the medicine session.
- Know the person before asking them to enter a vulnerable altered state.
- Treat integration as psychotherapy, not an optional debrief.
- Use the therapeutic approach that fits the client rather than forcing every experience into one model.
- Measure change by what happens in the person’s life, not only by how meaningful the dosing session felt.
At Serenity, Ketamine-Assisted Psychotherapy includes preparation, supported dosing, and structured integration. Integration may draw from ACT, IFS-informed therapy, EMDR, trauma-informed work, and other evidence-informed approaches depending on the client’s needs.
What Does the Research Still Not Know?
The field has made meaningful progress, but important questions remain.
Researchers still do not know the ideal number of preparation or integration sessions for every diagnosis or every psychedelic.
There is no universally agreed-upon psychotherapy model.
Studies vary in therapist training, therapeutic orientation, preparation length, integration structure, setting, and how outcomes are measured.
A 2024 systematic review of psychedelic therapy and evidence-based psychotherapy specifically highlighted the lack of consensus about how best to combine psychedelic experiences with established psychotherapy models.
More recent reviews continue to call for better measurement of the entire intervention – not only what happens during the acute drug experience.
That uncertainty does not make preparation and integration unimportant.
It means the field is now asking more precise questions about how to do them well.
Preparation and Integration in Cypress, Texas
Serenity Wellness and Counseling Center is located in Cypress, Texas, serving Cypress and surrounding Northwest Houston communities.
We do not offer psilocybin-assisted therapy at Serenity.
We do provide Ketamine-Assisted Psychotherapy for appropriately screened clients and bring lessons from psychotherapy, medicine-assisted therapy research, trauma treatment, ACT, IFS-informed work, EMDR, and whole-person care into the way we structure preparation and integration.
If you are considering KAP, you can learn more about Ketamine-Assisted Psychotherapy at Serenity or review our article on What Happens During Ketamine Integration? for a more detailed look at the integration process.
The medicine experience may open a door. Preparation helps you approach it with intention. Integration helps you decide what you want to carry through it.
Considering Ketamine-Assisted Psychotherapy?
At Serenity, KAP is not just a dosing appointment. Preparation, the medicine experience, and integration are treated as connected parts of the therapeutic process.
Learn more about Ketamine-Assisted Psychotherapy in Cypress, Texas
What to know before your first ketamine therapy session
Contact Serenity Wellness and Counseling Center
Frequently Asked Questions
What is preparation in psychedelic-assisted therapy?
Preparation is the therapeutic and practical work completed before a psychedelic dosing session. It commonly includes education, safety planning, discussion of expectations and intentions, building the therapeutic relationship, identifying supports and coping resources, and helping the person understand how to approach difficult or unfamiliar experiences.
Why is preparation important before a psychedelic experience?
Preparation can help establish trust, clarify expectations, identify potential challenges, and create a shared plan for the dosing experience. Modern psilocybin-assisted therapy protocols consistently include preparation, although the specific methods and number of sessions vary.
What is psychedelic integration?
Integration is the process of understanding what happened during and after a psychedelic experience and applying what is useful to everyday life. It may involve emotional processing, values work, trauma therapy, relationship work, behavioral change, or simply giving the experience time and space to become clearer.
Does every psychedelic experience need to be interpreted?
No. Not every image, sensation, memory, or unusual experience needs a hidden meaning. Integration can explore what feels personally important without forcing an interpretation or treating uncertain material as fact.
Does Serenity provide psilocybin-assisted therapy?
No. Serenity does not provide psilocybin treatment. Members of Serenity’s clinical team participate as therapists in approved psychedelic-assisted therapy research settings outside of Serenity. Serenity provides Ketamine-Assisted Psychotherapy when clinically appropriate.
Do you use ACT, IFS, or EMDR during integration?
In Serenity’s KAP work, integration may draw from ACT, IFS-informed therapy, EMDR, trauma-informed psychotherapy, and other appropriate interventions depending on the client and what emerges. In research settings, therapists follow the approved protocol for that particular study.
Is integration just one session after dosing?
Not necessarily. Different research and clinical models use different numbers of integration sessions. At Serenity, KAP includes structured integration between dosing experiences, with the amount of therapy based on the client’s needs, response, and treatment goals.
About the Author
Nicole Bankhead, LPC, is the owner and director of Serenity Wellness and Counseling Center in Cypress, Texas. Her clinical work includes psychotherapy and Ketamine-Assisted Psychotherapy, and she participates as a therapist in psychedelic-assisted therapy research conducted within approved clinical research settings. Her work emphasizes preparation, integration, psychological flexibility, trauma-informed care, and helping clients translate meaningful experiences into changes in everyday life.
Meet Nicole and the Serenity team
Continue Exploring
- What Happens During Ketamine Integration?
- What Does Psychological Flexibility Actually Mean?
- Why Insight Alone Doesn’t Always Create Change
- What Does Whole-Person Mental Health Care Actually Mean?
- Ketamine and Psilocybin Aren’t the Same: Understanding Different Forms of Medicine-Assisted Therapy
Sources & Further Reading
- Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review. 2024.
https://pubmed.ncbi.nlm.nih.gov/38850581/ - Horton DM, Morrison B, Schmidt J. Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy. American Journal of Psychotherapy. 2021.
https://pubmed.ncbi.nlm.nih.gov/34293927/ - The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. 2024.
https://pubmed.ncbi.nlm.nih.gov/38483940/ - Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review. 2025.
https://pubmed.ncbi.nlm.nih.gov/40353492/ - Psychedelic integration: An analysis of the concept and its practice. 2022.
https://pubmed.ncbi.nlm.nih.gov/35992410/ - Psychedelics and Evidence-based Psychotherapy: A Systematic Review with Recommendations for Advancing Psychedelic Therapy Research. 2024.
https://pubmed.ncbi.nlm.nih.gov/38724126/ - Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis. 2026.
https://pubmed.ncbi.nlm.nih.gov/41563753/ - Mechanisms of integration in psychedelic-assisted therapy. 2026.
https://pubmed.ncbi.nlm.nih.gov/42533988/ - Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation. 2023.
https://pubmed.ncbi.nlm.nih.gov/36707036/ - UT MD Anderson Cancer Center. TRIP – Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer.
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2022-0170.html - UT MD Anderson Cancer Center. TRIPS – Psilocybin-Assisted Psychotherapy in Cancer Survivors.
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2024-1663.html
This article is for educational purposes and is not medical advice. Serenity Wellness and Counseling Center does not provide psilocybin-assisted therapy. Psilocybin remains investigational for the clinical uses discussed here. Members of Serenity’s clinical team participate in psychedelic-assisted therapy research only within approved research settings. Ketamine-Assisted Psychotherapy has different pharmacology, legal status, and evidence than classic psychedelic-assisted therapy, and findings should not be assumed to transfer directly from one medicine to another.
